for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Britain looking into AstraZeneca-Alexion deal for competition concerns

May 25 (Reuters) - Britain’s competition regulator said on Tuesday it was probing if AstraZeneca’s $39 billion takeover of U.S. drugmaker Alexion could reduce competition for products and services in the country or elsewhere. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Devika Syamnath)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up